How should warfarin be rapidly reversed in a patient with an intracerebral hemorrhage who has a mechanical mitral valve prosthesis?

Immediate Warfarin Reversal with Prothrombin Complex Concentrate and Vitamin K

In a patient with intracerebral hemorrhage on warfarin for a mechanical mitral valve, immediately reverse anticoagulation with prothrombin complex concentrate (PCC) 25 IU/kg combined with intravenous vitamin K 10 mg, regardless of INR availability. 1

Urgent Reversal Protocol

For intracranial bleeding specifically, the threshold for reversal is lower than other bleeding sites:

• Stop warfarin immediately upon ICH diagnosis 1
• Administer PCC (25 IU/kg) if INR >1.2 for intracranial hemorrhage (note: this is lower than the >1.5 threshold for other severe bleeding) 1
• Give vitamin K 10 mg IV or PO concurrently with PCC 1
• Check INR within 30 minutes of reversal, then again at 6-8 hours and 24 hours to determine if additional PCC/vitamin K is needed 1

Why PCC Over Fresh Frozen Plasma

PCC is strongly preferred over FFP because it:

• Corrects INR more rapidly 1
• Requires substantially lower infusion volumes (critical to avoid volume overload) 2, 3
• Reduces mortality by half in warfarin-associated ICH when combined with vitamin K 1

FFP is only reasonable when PCC is unavailable 4, 2, but carries higher risk of volume overload and slower correction time.

Critical Pitfall: Avoid High-Dose Vitamin K Alone

Do not give high-dose vitamin K (>10 mg) without PCC 4. High-dose vitamin K alone:

• Creates a hypercoagulable state 4
• Takes hours to work (too slow for ICH)
• Makes subsequent re-anticoagulation extremely difficult 2

The High-Risk Dilemma: Mechanical Mitral Valve

This patient faces competing catastrophic risks:

Thromboembolism risk while off anticoagulation:

• Mechanical mitral valves carry higher thrombotic risk than aortic valves 4, 5
• Any mechanical mitral valve replacement is classified as high thrombotic risk 4, 2
• Stroke risk is approximately 4-12% per year without anticoagulation 6, 7
• During the 7-10 days off warfarin, thromboembolic events occur in approximately 5% of patients 6, 7

Hemorrhagic expansion risk with anticoagulation:

• Restarting anticoagulation causes hemorrhagic complications in 26% of mechanical valve patients with ICH 8
• Early resumption (before Day 6) significantly increases composite risk of bleeding and thrombosis 8

When to Resume Anticoagulation

Based on the highest quality recent evidence:

Hold anticoagulation for at least 6-14 days after ICH 8, 9, 10:

• Day 6 is the earliest safe restart point when balancing both hemorrhagic and thromboembolic risks 8
• Day 7-14 appears optimal for most patients, with lower hemorrhagic recurrence rates 6, 7, 8, 9, 10
• Restarting before Day 13 carries significantly increased hemorrhagic risk (HR 7.06) 8

Bridging Strategy Upon Resumption

When restarting anticoagulation:

Consider warfarin alone without heparin bridging 9:

• One case series showed successful outcomes restarting warfarin at Day 14 without heparin bridge 9
• If bridging is deemed necessary due to extreme thrombotic risk, use IV unfractionated heparin (not LMWH) because it has the shortest half-life and can be rapidly reversed with protamine if rebleeding occurs 11
• Target therapeutic INR 2.5-3.5 for mechanical mitral valves 4, 3

Monitoring During the Off-Anticoagulation Period

While holding anticoagulation for 7-14 days:

• Serial neuroimaging is essential—delayed hemorrhage can occur even with initially negative CT 12
• Prophylactic-dose subcutaneous heparin may be considered after initial hemorrhage stabilization (typically after 48-72 hours), but this remains controversial 4
• Do NOT use therapeutic anticoagulation during this window 8

Key Clinical Factors Affecting Timing

Delay resumption beyond 14 days if:

• Large hematoma volume (>30 cc) 13
• Significant midline shift 13
• Intraventricular extension 13
• Lobar location suggesting amyloid angiopathy (especially in elderly) 6, 7, 6
• Evidence of multiple microbleeds on MRI 5

Consider earlier resumption (Day 6-7) only if:

• Small deep hemorrhage 6
• Stable repeat imaging
• Extremely high thrombotic risk (e.g., recent valve thrombosis history)
• Younger patient without amyloid risk factors

Common Pitfalls to Avoid

1. Delaying reversal to wait for INR results—start PCC/vitamin K immediately in ICH 1
2. Using FFP when PCC is available—PCC is superior 1, 2
3. Restarting anticoagulation too early (<6 days)—hemorrhagic risk outweighs benefit 8
4. Assuming initial negative CT rules out ICH—repeat imaging with new symptoms 12
5. Using heparin bridge routinely—may increase bleeding risk; consider warfarin alone 9